Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.36 |
| ▸ | PRKCA | P17252 | 1/20 | 0.32 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.31 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.31 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.31 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | CA7 | P43166 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Water SCHEMBL11753275 | 0.97 | ALOX15 (0.38) | ALOX15TSHRDGAT1PRKCACHRM2 | |
| SCHEMBL10295467 | 0.82 | DGAT1 (0.34) | DGAT1GAA | |
| SCHEMBL10295313 | 0.82 | DGAT1 (0.34) | DGAT1GAA | |
| SCHEMBL510534 | 0.80 | DGAT1 (0.33) | DGAT1 | |
| SCHEMBL1320078 | 0.80 | DGAT1 (0.33) | ALOX15DGAT1 | |
| SCHEMBL29874055 | 0.80 | DGAT1 (0.33) | DGAT1 | |
| SCHEMBL1320080 | 0.80 | DGAT1 (0.33) | ALOX15DGAT1 | |
| SCHEMBL15482560 | 0.80 | DGAT1 (0.33) | DGAT1 | |
| SCHEMBL510535 | 0.80 | DGAT1 (0.33) | DGAT1 | |
| SCHEMBL8416376 | 0.78 | DGAT1 (0.32) | DGAT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-106977383-A | A kind of method for preparing citral | 万华化学集团股份有限公司 | 2017-07-25 | — | — | CN | claimed |
| US-8067644-B2 | Process for conducting an organic reaction in ionic liquids | THE PROCTER & GAMBLE COMPANY (US) | 2011-11-29 | — | — | US | claimed |
| EP-2370387-A2 | PROCESS FOR CONDUCTING AN ORGANIC REACTION IN IONIC LIQUIDS | The Procter & Gamble Company (US) | 2011-10-05 | — | — | EP | claimed |
| US-20110152566-A1 | Process for Conducting an Organic Reaction in Ionic Liquids | THE PROCTER & GAMBLE COMPANY | 2011-06-23 | — | — | US | claimed |
| WO-2010080505-A2 | PROCESS FOR CONDUCTING AN ORGANIC REACTION IN IONIC LIQUIDS | THE PROCTER & GAMBLE COMPANY (US) | 2010-07-15 | — | — | WO | claimed |
| US-9840640-B2 | Article having antifouling properties for aquatic and particularly sea use | BLUESTAR SILICONES FRANCE (FR) | 2017-12-12 | — | — | US | disclosed |
| US-9840640-B2 | Article having antifouling properties for aquatic and particularly sea use | BLUESTAR SILICONES FRANCE (FR) | 2017-12-12 | — | — | US | disclosed |
| EP-2868651-B1 | Method for producing 2-isopropylidene-5-methyl-4-hexenyl butyrate | SHINETSU CHEMICAL CO (JP) | 2017-08-09 | — | — | EP | disclosed |
| US-20170210701-A1 | SUBSTITUTED CYANO CYCLOALKYL PENTA-2,4-DIENES, CYANO CYCLOALKYL PENT-2-EN-4-YNES, CYANO HETEROCYCLYL PENTA-2,4-DIENES AND CYANO HETEROCYCLYL PENT-2-EN-4-YNES AS ACTIVE SUBSTANCES | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2017-07-27 | — | — | US | disclosed |
| CN-106977383-A | A kind of method for preparing citral | 万华化学集团股份有限公司 | 2017-07-25 | — | — | CN | disclosed |
| US-9359553-B2 | Liquid crystal composition and liquid crystal display device | JNC CORPORATION (JP) | 2016-06-07 | — | — | US | disclosed |
| WO-2016012362-A1 | SUBSTITUTED CYANO CYCLOALKYL PENTA-2,4-DIENES, CYANO CYCLOALKYL PENT-2-EN-4-YNES, CYANO HETEROCYCLYL PENTA-2,4-DIENES AND CYANO HETEROCYCLYL PENT-2-EN-4-YNES AS ACTIVE SUBSTANCES AGAINST ABIOTIC PLANT STRESS | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2016-01-28 | — | — | WO | disclosed |
| US-20110212333-A1 | ARTICLE HAVING ANTIFOULING PROPERTIES FOR AQUATIC AND PARTICULARLY SEA USE | BLUESTAR SILICONES FRANCE (FR) | 2011-09-01 | — | — | US | disclosed |
| US-20110212333-A1 | ARTICLE HAVING ANTIFOULING PROPERTIES FOR AQUATIC AND PARTICULARLY SEA USE | BLUESTAR SILICONES FRANCE (FR) | 2011-09-01 | — | — | US | disclosed |
| US-20110152566-A1 | Process for Conducting an Organic Reaction in Ionic Liquids | THE PROCTER & GAMBLE COMPANY | 2011-06-23 | — | — | US | disclosed |
| WO-2010080505-A2 | PROCESS FOR CONDUCTING AN ORGANIC REACTION IN IONIC LIQUIDS | THE PROCTER & GAMBLE COMPANY (US) | 2010-07-15 | — | — | WO | disclosed |
| EP-0780386-B1 | Matrix metalloprotease inhibitors | HOFFMANN LA ROCHE (CH) | 2002-10-02 | — | — | EP | disclosed |
| US-6342627-B1 | ESTER INTERCHANGE WITH ALCOHOL IN THE PRESENCE OF LANTHANOIDE METAL ALKOXIDE | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2002-01-29 | — | — | US | disclosed |
| US-5932595-A | ANTIARTHRITIC AGENT; MULTIPLE SCLEROSIS; OSTEOPOROSIS; RESPIRATORY SYSTEM DISORDERS; SKIN DISORDERS; ANTIULCER AGENT | SYNTEX (U.S.A.) INC. (US) | 1999-08-03 | — | — | US | disclosed |
| EP-0780386-A1 | Matrix metalloprotease inhibitors | F. HOFFMANN-LA ROCHE AG (CH) | 1997-06-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170210701-A1 | SUBSTITUTED CYANO CYCLOALKYL PENTA-2,4-DIENES, CYANO CYCLOALKYL PENT-2-EN-4-YNES, CYANO HETEROCYCLYL PENTA-2,4-DIENES AND CYANO HETEROCYCLYL PENT-2-EN-4-YNES AS ACTIVE SUBSTANCES | CBR3, NPY2R, CBR1 | ALOX15 1173/4885TSHR 2831/4885DGAT1 2896/4885 |
| US-20110152566-A1 | Process for Conducting an Organic Reaction in Ionic Liquids | ACSL3, ACSL1, MCOLN1 | ALOX15 50/4885TSHR 3361/4885DGAT1 518/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.